Newman Dignan & Sheerar Inc’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.7K | Hold |
22,915
| – | – | ﹤0.01% | 192 |
|
|
2025
Q1 | $12.6K | Hold |
22,915
| – | – | ﹤0.01% | 174 |
|
|
2024
Q4 | $20.9K | Buy |
22,915
+900
| +4% | +$822 | 0.01% | 178 |
|
|
2024
Q3 | $26.9K | Buy |
+22,015
| New | +$26.9K | 0.01% | 184 |
|
|
2024
Q1 | – | Sell |
-22,015
| Closed | -$29.7K | – | 179 |
|
|
2023
Q4 | $29.7K | Buy |
+22,015
| New | +$29.7K | 0.01% | 175 |
|
|
2023
Q3 | – | Sell |
-18,915
| Closed | -$49.2K | – | 176 |
|
|
2023
Q2 | $49.2K | Hold |
18,915
| – | – | 0.02% | 181 |
|
|
2023
Q1 | $22.7K | Hold |
18,915
| – | – | 0.01% | 190 |
|
|
2022
Q4 | $30.8K | Buy |
18,915
+6,000
| +46% | +$9.78K | 0.01% | 185 |
|
|
2022
Q3 | $16 | Buy |
+12,915
| New | +$16 | ﹤0.01% | 180 |
|
|
2022
Q2 | – | Sell |
-12,915
| Closed | -$20 | – | 195 |
|
|
2022
Q1 | $20 | Sell |
12,915
-1,000
| -7% | -$2 | ﹤0.01% | 194 |
|
|
2021
Q4 | $19K | Buy |
13,915
+1,000
| +8% | +$1.37K | 0.01% | 201 |
|
|
2021
Q3 | $27K | Buy |
+12,915
| New | +$27K | 0.01% | 191 |
|